| Entry |
|
| Name |
Desirudin (USAN/INN); Iprivask (TN) |
| Formula |
C287H440N80O110S6
|
| Exact mass |
6958.9620
|
| Mol weight |
6963.44
|
| Sequence |
VVYTDCTESG QNLCLCEGSN VCGQGNKCIL GSDGEKNQCV TGEGTPKPQS HNDGDFEEIP EEYLQ (Disulfide bridge: 6-14, 16-28, 22-39) |
| Type |
Peptide |
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
|
| Remark |
|
| Efficacy |
Anticoagulant, Thrombin inhibitor |
| Comment |
Peptide
Hirudin derivative
|
| Target |
|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
| Interaction |
|
| Structure map |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE Direct thrombin inhibitors
B01AE01 Desirudin
D03692 Desirudin (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
D03692 Desirudin
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
F2a
D03692 Desirudin (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|